{"bill":{"bill_id":1669715,"change_hash":"b0fbd134e478b35d9d6a26fa6edabe06","session_id":1998,"session":{"session_id":1998,"state_id":24,"year_start":2023,"year_end":2023,"prefile":0,"sine_die":0,"prior":0,"special":0,"session_tag":"Regular Session","session_title":"2023 Regular Session","session_name":"2023 Regular Session"},"url":"https:\/\/legiscan.com\/MS\/bill\/HB1071\/2023","state_link":"http:\/\/billstatus.ls.state.ms.us\/2023\/pdf\/history\/HB\/HB1071.xml","completed":0,"status":2,"status_date":"2023-02-07","progress":[{"date":"2023-01-16","event":1},{"date":"2023-01-16","event":9},{"date":"2023-02-07","event":2},{"date":"2023-02-13","event":9}],"state":"MS","state_id":24,"bill_number":"HB1071","bill_type":"B","bill_type_id":"1","body":"H","body_id":57,"current_body":"S","current_body_id":58,"title":"Uniform Controlled Substances Act; revise schedules.","description":"An Act To Amend Section 41-29-113, Mississippi Code Of 1972, To Include Sixteen Substances As Schedule I Controlled Substances Because These Drugs Have No Legitimate Medical Use And Have A High Potency With Great Potential To Cause Harm; To Amend Section 41-29-119, Mississippi Code Of 1972, To Include Serdexmethylphenidate As A Schedule Iv Controlled Substance Because The Drug Has A Currently Accepted Medical Use And A Low Potential For Abuse That May Lead To Limited Physical Dependence Or Psychological Dependence Relative To The Drugs Or Other Substances In Schedule Iii; And For Related Purposes.","pending_committee_id":0,"committee":[],"referrals":[{"date":"2023-01-16","committee_id":3446,"chamber":"H","chamber_id":57,"name":"Drug Policy"},{"date":"2023-02-13","committee_id":1995,"chamber":"S","chamber_id":58,"name":"Drug Policy"}],"history":[{"date":"2023-01-16","action":"Referred To Drug Policy","chamber":"H","chamber_id":57,"importance":1},{"date":"2023-01-25","action":"Title Suff Do Pass","chamber":"H","chamber_id":57,"importance":0},{"date":"2023-02-07","action":"Passed","chamber":"H","chamber_id":57,"importance":1},{"date":"2023-02-08","action":"Transmitted To Senate","chamber":"H","chamber_id":57,"importance":0},{"date":"2023-02-13","action":"Referred To Drug Policy","chamber":"S","chamber_id":58,"importance":1},{"date":"2023-02-24","action":"Title Suff Do Pass","chamber":"S","chamber_id":58,"importance":0}],"sponsors":[{"people_id":6617,"person_hash":"3yx14ihx","party_id":"2","state_id":24,"party":"R","role_id":1,"role":"Rep","name":"Lee Yancey","first_name":"Lee","middle_name":"","last_name":"Yancey","suffix":"","nickname":"","district":"HD-074","ftm_eid":6673226,"votesmart_id":69828,"opensecrets_id":"","knowwho_pid":260584,"ballotpedia":"Lee_Yancey","bioguide_id":"","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[],"subjects":[],"texts":[{"doc_id":2651587,"date":"2023-01-19","type":"Introduced","type_id":1,"mime":"text\/html","mime_id":1,"url":"https:\/\/legiscan.com\/MS\/text\/HB1071\/id\/2651587","state_link":"http:\/\/billstatus.ls.state.ms.us\/documents\/2023\/html\/HB\/1000-1099\/HB1071IN.htm","text_size":83659,"text_hash":"dbf6f716d0f5d6a899326443a4e56298"},{"doc_id":2689399,"date":"2023-02-08","type":"Engrossed","type_id":4,"mime":"text\/html","mime_id":1,"url":"https:\/\/legiscan.com\/MS\/text\/HB1071\/id\/2689399","state_link":"http:\/\/billstatus.ls.state.ms.us\/documents\/2023\/html\/HB\/1000-1099\/HB1071PS.htm","text_size":83918,"text_hash":"72e12a569f6e03f80dda17aa413982b3"}],"votes":[{"roll_call_id":1245201,"date":"2023-02-07","desc":"House Passed","yea":116,"nay":2,"nv":2,"absent":0,"total":120,"passed":1,"chamber":"H","chamber_id":57,"url":"https:\/\/legiscan.com\/MS\/rollcall\/HB1071\/id\/1245201","state_link":"http:\/\/billstatus.ls.state.ms.us\/2023\/pdf\/votes\/house\/0360013.pdf"}],"amendments":[],"supplements":[],"calendar":[]}}